Previous 10 | Next 10 |
Accuray TomoTherapy® Helical Radiotherapy System Helps Preserve Breast Cancer Patients' Long-term Heart and Lung Functionality - Phase III, randomized controlled trial results highlight patient reported outcomes at 10 years'follow-up - TomoTherapy delivered hypofraction...
Accuray had a good quarter with respect to product revenue and orders, but gross margins were weak on supply chain issues. Supply chain issues led management to halve near-term EBITDA guidance, with margins and profits likely to retreat to multiyear lows. The financial shortfall m...
Accuray to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference Accuray to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference PR Newswire SUNNYVALE, Calif. , Feb. 7, 2022 ...
Gainers: Alnylam Pharmaceuticals (NASDAQ:ALNY) +12%. ImmunityBio (NASDAQ:IBRX) +6%. Ortho Clinical Diagnostics Holdings (NASDAQ:OCDX) +5%. Qorvo (NASDAQ:QRVO) +5%. Vanda Pharmaceuticals (NASDAQ:VNDA) +4%. Losers: COMPASS Pathways P(NASDAQ:CMPS) +-5%. GreenSky (NASD...
Image source: The Motley Fool. Accuray (NASDAQ: ARAY) Q2 2022 Earnings Call Jan 26, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Accuray (ARAY) Q2 2022 Earnings Call Transcript
Accuray Reports Fiscal 2022 Second Quarter Financial Results Record Revenue For Second Quarter Fiscal 2022 PR Newswire SUNNYVALE, Calif. , Jan. 26, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the second quarte...
Accuray to Report Second Quarter Fiscal 2022 Financial Results on January 26, 2022 PR Newswire SUNNYVALE, Calif. , Jan. 12, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2022, end...
Accuray CyberKnife® Robotic Radiosurgery System Receives Shonin Approval to Treat Trigeminal Neuralgia, a Chronic Pain Condition Affecting a Facial Nerve - Trigeminal neuralgia, a persistent neurological disorder, is described by some patients as the most excruciating pain ...
Accuray's better than expected fiscal first quarter results underline ongoing progress in the story. Focused R&D efforts have significantly upgraded the capabilities and appeal of Accuray's systems, particularly on the software side. Accuray's JV to produce Type B systems in C...
The following slide deck was published by Accuray Incorporated in conjunction with this event. For further details see: Accuray (ARAY) Presents At 2021 Virtual Healthcare Conference - Slideshow
News, Short Squeeze, Breakout and More Instantly...
Heidelberg University Hospital in Germany Invests in Fourth Accuray Radiotherapy Device, the Radixact® System, to Improve Cancer Patient Care PR Newswire The Radixact System will be supplied with ClearRT ® , Synchrony ® , and the VOLO™ Ultra Optim...
Accuray and TrueNorth Medical Physics Sign Agreement to Provide Radiation Oncology Support Intended to Advance Cancer Care for More Patients PR Newswire MADISON, Wis. , June 20, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today an agreement...